Being Female Is Not a Risk Factor
Inside the Architecture of Women's Health Event: what reinsurers, governments, and screening guidelines are actually getting wrong — and who's already fixing it.
Last week, this newsletter described the coordination failure: every sector waiting for another to move first.
Today, the full report of the “Architecture of Women’s Health” live — and it contains the sector-by-sector evidence, the specific policy mechanisms, and the action pathways that make “waiting” to fix the gaps in women’s health no longer economically defensible.
This is what’s in it:
The insurance model is backwards
Actuarial models currently use sex as a proxy for variables they have never measured directly.
When an insurer raises a premium because a woman has a family history of breast or ovarian cancer, is it pricing genetic risk? Or is it pricing the absence of early detection infrastructure?
When Swiss supplementary insurance charges women more than men — the only country in Europe to do so — how much of that premium reflects biology, and how much reflects a system that diagnoses women later and routes them through more expensive late-stage pathways because it missed the window?
The data to answer those questions does not exist yet. And that is the point.
The report surfaces a reframing : life and health insurers operate on a decades-long horizon. If women live longer and healthier, both insurer and policyholder benefit. The incentives are directly aligned. Yet the industry treats pregnancy as a pre-existing condition, raises rates for postpartum depression, and penalizes family history of gynecological cancers — rather than using that same knowledge to fund prevention.
The shift proposed: from risk pricing to risk prevention. Some life insurers are already offering multi-cancer early detection testing to policyholders — screening for 50+ cancers — because catching disease earlier is cheaper for everyone.
But the more powerful lever sits one level up. Reinsurers set the terms that shape what primary insurers do. If reinsurance contracts build in favorable terms for insurers that fund early detection or adopt pathway-level data, the entire insurance market shifts — without requiring each insurer to make the business case independently.
The governance playbook already exists — in three countries
The report documents what three governments are already doing. Not planning. Doing.
Finland passed one of Europe’s most advanced health data laws — mandating sex-disaggregated collection across all national registries. A dedicated women’s health innovation hub in Turku connecting pharma, biotech, universities, and providers has received parliamentary funding. The Finnish government recognized menopause in policy for the first time and enacted occupational health guidelines for it. And in December 2025, a Nordic Charter set a time-bound target: parity in healthy life years between women and men by 2040.
California is mandating health data exchange accountability across all government-funded prenatal care. The logic: pregnancy complications — preeclampsia, gestational diabetes, preterm birth — carry a 2–4x lifetime cardiovascular risk. Pregnancy is not a reproductive event. It is a cardiovascular stress test. And the system currently loses that signal the moment a woman is discharged postpartum. 80% of maternal deaths in the U.S. are preventable.
Australia is embedding gender analysis into all government policy proposals and making significant public investment in reducing cost barriers for women across the life course — essential medicines, primary care, mental health, and reproductive healthcare. Community-led models, such as birthing programs designed by and for indigenous communities, are outperforming top-down interventions.
The governance lesson that emerged across all three: sex-disaggregated data collection must become a baseline legal standard. Not a best practice. Not a voluntary reporting option. The countries that mandate it build the data infrastructure that every other actor — pharma, insurers, researchers, AI developers — then needs to move.
Why Switzerland is an interesting place to watch
Health insurance, disability insurance, old-age pensions, and gender equality policy all fall under a single federal department — the Federal Department of Home Affairs.
That creates an unusual structural possibility. The full cascade of a missed diagnosis — from health costs, to disability support, to earlier workforce exit, to longer pension drawdown — could, in principle, be traced within one department’s mandate. Most countries scatter those costs across ministries that never compare notes.
Switzerland also happens to have two reform windows open simultaneously. TARDOC, the new outpatient tariff system that replaced TARMED in January 2026, is reshaping how outpatient care is billed. EFAS, the uniform financing reform approved by Swiss voters in November 2024, will restructure how costs are shared between cantons and insurers starting in 2028 — and the implementation framework is being designed now. If there were ever a moment to explore embedding sex-differentiated cost modeling into reimbursement architecture, it would be while the architecture is still being drawn.
Add to that ETH Zurich and EPFL, a globally significant pharmaceutical ecosystem, and one of the world’s deepest financial and insurance sectors — and the ingredients for something genuinely new are sitting in close proximity. Whether and how they come together is the open question.
The screening timeline is indefensible
One of the starkest sections of the report maps when biological risk begins versus when screening starts — condition by condition.
Bone health decline begins in the mid-40s during menopause. Osteoporosis screening starts at 65. That is a 20-year gap.
Cardiovascular risk accelerates at menopause. Routine cardiovascular screening for women is not linked to menopausal status at all.
Ovarian cancer has no routine screening. Most insurance does not cover it. Prostate cancer screening is covered.
There is no standardized screening protocol for menopause itself — despite the fact that 40% of women’s lives will be spent in it, and menopause is a known risk factor for cardiovascular disease, osteoporosis, cognitive decline, and metabolic syndrome.
Every year of delayed screening is a year of avoidable late-stage cost. The evidence base for earlier screening exists. What is missing is the reimbursement and regulatory alignment to act on it.
The pension cascade
The report traces a compounding financial penalty that runs from diagnosis to retirement:
Women earn less. Pay more for healthcare — 18% more in out-of-pocket costs on U.S. employer plans. Get diagnosed later — four years on average across 700+ diseases. Accumulate preventable morbidity — 25% more time in poor health. Exit the workforce earlier — three in five women retire earlier than planned, the number-one reason being health. Draw smaller pensions. Live longer in poor health. Two-thirds of pensioners in poverty globally are women.
These are not separate problems. It is one cascade.
Read the report. Send it to the person who needs to see it.
It covers governance, clinical systems, pharma, and finance — with specific action pathways organized from what can be done now to what no one has tried yet.
Then think about who in your world would find this useful. Not “interesting” — useful. The person who actually sets reimbursement codes, prices insurance products, allocates R&D budget, designs screening guidelines, or writes health policy. The person who keeps running into the same wall from their side and doesn’t have visibility into what the other sectors need to move.
That’s who this was written for. Forward it to them.
And if your organization wants to explore piloting any of the approaches in the report — whether that’s mapping diagnostic delay costs inside a specific system, building sex-specific evidence into clinical AI, or designing prevention-oriented insurance products — FemTechnology would welcome that conversation: oriana@femtechnology.org
The cascade of compounding financial penalty has to be one of the simplest and most brilliant representations of how interconnected each of these systems and issues is! 👏🏽